Physician profile
Kasey E Treger
NPI 1316238496
$36,545.88
in general payments reported to CMS, 2019-2025
27 companies · $8,642 in 2025
The $8,642 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,616 · 2020: $219 · 2021: $297 · 2022: $1,420 · 2023: $10K · 2024: $14K · 2025: $8,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $14K · Food and Beverage: $4,037 · Travel and Lodging: $1,414 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,950.00 |
| Consulting Fee | $13,575.00 |
| Food and Beverage | $4,037.28 |
| Travel and Lodging | $1,413.99 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17,027.39 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Genzyme Corporation | $16,539.94 | 2019-2025 | |
| Glaxosmithkline, LLC. | $877.28 | 2019-2025 | Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $506.52 | 2019-2024 | Ofev |
| Actelion Pharmaceuticals US, INC. | $167.16 | 2019-2021 | |
| Genentech USA, INC. | $155.08 | 2019 | |
| Intuitive Surgical, INC. | $151.91 | 2022-2024 | Da Vinci Surgical System |
| Insmed, INC. | $149.33 | 2025 | Arikayce |
| Philips North America LLC | $135.59 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $132.23 | 2022 | |
| Novo Nordisk INC | $111.28 | 2022 | |
| United Therapeutics Corporation | $100.00 | 2020 | |
| Veran Medical Technologies, INC. | $85.53 | 2019 | |
| Grifols USA, LLC | $49.90 | 2019 | |
| 3b Medical, INC. | $46.87 | 2025 | Luna |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $41.12 | 2019 | |
| Mallinckrodt Enterprises LLC | $36.63 | 2019 | |
| Electromed, INC. | $32.21 | 2023 | Smartvest |
| E.R. Squibb & Sons, L.L.C. | $31.36 | 2019 | |
| Allergan, INC. | $25.99 | 2019 | |
| Gilead Sciences, INC. | $25.66 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.21 | 2019 | |
| Inspire Medical Systems, INC. | $23.82 | 2023 | Inspire |
| Regeneron Healthcare Solutions, INC. | $21.56 | 2019 | |
| Csl Behring | $18.02 | 2019 | |
| Medtronic, INC. | $17.38 | 2023 | Illumisite |
| Bayer Healthcare Pharmaceuticals INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kasey Treger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.